UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

3D MPRAGE improves classification of cortical lesions in multiple sclerosis

Multiple sclerosis, 2008-11, Vol.14 (9), p.1214-1219

2008

Volltextzugriff (PDF)

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

The New England journal of medicine, 2017-01, Vol.376 (3), p.221-234

2017

Volltextzugriff (PDF)

Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis

The New England journal of medicine, 2011-10, Vol.365 (14), p.1293-1303

2011

Volltextzugriff (PDF)

Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial

Lancet neurology, 2014-03, Vol.13 (3), p.247-256

2014

Volltextzugriff (PDF)

Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial

Lancet neurology, 2014-10, Vol.13 (10), p.977-986

2014

Volltextzugriff (PDF)

Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trial

Multiple sclerosis, 2014-05, Vol.20 (6), p.705-716

2014

Volltextzugriff (PDF)

Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria"

Annals of neurology, 2005-12, Vol.58 (6), p.840-846

2005

Volltextzugriff (PDF)

Prognosis of the individual course of disease--steps in developing a decision support tool for Multiple Sclerosis

BMC medical informatics and decision making, 2007-05, Vol.7 (1), p.11-11, Article 11

2007

Volltextzugriff (PDF)

Polygenicity of Comorbid Depression in Multiple Sclerosis

Neurology, 2023-08, Vol.101 (5), p.e522

2023

Volltextzugriff (PDF)

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

Annals of neurology, 2001-07, Vol.50 (1), p.121-127

2001

Volltextzugriff (PDF)

Magnetic resonance imaging outcomes from a phase III trial of teriflunomide

Multiple sclerosis, 2013-09, Vol.19 (10), p.1310-1319

2013

Volltextzugriff (PDF)

Teriflunomide added to interferon-β in relapsing multiple sclerosis: a randomized phase II trial

Neurology, 2012-06, Vol.78 (23), p.1877-1885

2012

Volltextzugriff (PDF)

Standardized MR imaging protocol for multiple sclerosis : Consortium of MS centers consensus guidelines

AJNR. American journal of neuroradiology, 2006-02, Vol.27 (2), p.455-461

2006

Volltextzugriff (PDF)

Pre-specified subgroup analyses of a placebo-controlled phase III trial (TEMSO) of oral teriflunomide in relapsing multiple sclerosis

Multiple sclerosis, 2012-11, Vol.18 (11), p.1625-1632

2012

Volltextzugriff (PDF)

Composite end points to assess delay of disability progression by MS treatments

Multiple sclerosis, 2014-10, Vol.20 (11), p.1494-1501

2014

Volltextzugriff (PDF)

MRI T2 lesion burden in multiple sclerosis: a plateauing relationship with clinical disability

Neurology, 2006-05, Vol.66 (9), p.1384-1389

2006

Volltextzugriff (PDF)

The efficacy of teriflunomide in patients who received prior disease-modifying treatments: Subgroup analyses of the teriflunomide phase 3 TEMSO and TOWER studies

Multiple sclerosis, 2018-04, Vol.24 (4), p.535-539

2018

Volltextzugriff (PDF)

Pooled safety and tolerability data from four placebo-controlled teriflunomide studies and extensions

Multiple sclerosis and related disorders, 2016-01, Vol.5, p.97-104

2016

Volltextzugriff (PDF)

Glatiramer acetate reduces the proportion of new MS lesions evolving into "black holes"

Neurology, 2001-08, Vol.57 (4), p.731-733

2001

Volltextzugriff (PDF)

Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients with Relapsing and Primary Progressive Multiple Sclerosis

Multiple sclerosis and related disorders, 2023-12, Vol.80, p.105308, Article 105308

2023

Volltextzugriff (PDF)

Diffusion tensor fractional anisotropy of the normal-appearing seven segments of the corpus callosum in healthy adults and relapsing-remitting multiple sclerosis patients

Journal of magnetic resonance imaging, 2005-06, Vol.21 (6), p.735-743

2005

Volltextzugriff (PDF)

Long-term safety and efficacy of teriflunomide in patients with relapsing multiple sclerosis: Results from the TOWER extension study

Multiple sclerosis and related disorders, 2020-11, Vol.46, p.102438-102438, Article 102438

2020

Volltextzugriff (PDF)

Polygenic liability for anxiety in association with comorbid anxiety in multiple sclerosis

Annals of clinical and translational neurology, 2024-06, Vol.11 (6), p.1393-1404

2024

Volltextzugriff (PDF)

Teriflunomide reduces relapse-related neurological sequelae, hospitalizations and steroid use

Journal of neurology, 2013-10, Vol.260 (10), p.2472-2480

2013

Volltextzugriff (PDF)

Association of Vitamin D Polygenic Risk Scores and Disease Outcome in People With Multiple Sclerosis

Neurology : neuroimmunology & neuroinflammation, 2023-01, Vol.10 (1)

2023

Volltextzugriff (PDF)

1 – 25 von 205

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(183)
Mit Volltextzugriff
(153)

Publikationsform

Sprache

Englisch
(204)

Erscheinungsjahr

n.n

Thema

Science & Technology
(185)
Life Sciences & Biomedicine
(181)
Humans
(129)
Neurosciences & Neurology
(110)
Clinical Neurology
(102)
Biological And Medical Sciences
(85)
Medical Sciences
(71)
Neurosciences
(66)
Male
(63)
Female
(59)
Adult
(54)
Neurology
(51)
Multiple Sclerosis
(49)
Magnetic Resonance Imaging
(42)
Middle Aged
(35)
Animals
(34)
Brain - Pathology
(32)
Medicin Och Hälsovetenskap
(32)
Multiple Sclerosis, Relapsing-Remitting - Drug Therapy
(24)
Virology
(24)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Multiple Sclerosis
(24)
Neurology
(23)
Annals Of Neurology
(20)
Virology
(8)
Archives Of Neurology
(5)
Journal Of Virology
(5)
Lancet Neurology
(5)
Multiple Sclerosis And Related Disorders
(5)
The Journal Of Infectious Diseases
(5)
Archives Of Virology
(4)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

3D MPRAGE improves classification of cortical lesions in multiple sclerosis

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis

Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial

Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial

Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trial

Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria"

Prognosis of the individual course of disease--steps in developing a decision support tool for Multiple Sclerosis

Polygenicity of Comorbid Depression in Multiple Sclerosis

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

Magnetic resonance imaging outcomes from a phase III trial of teriflunomide

Teriflunomide added to interferon-β in relapsing multiple sclerosis: a randomized phase II trial

Standardized MR imaging protocol for multiple sclerosis : Consortium of MS centers consensus guidelines

Pre-specified subgroup analyses of a placebo-controlled phase III trial (TEMSO) of oral teriflunomide in relapsing multiple sclerosis

Composite end points to assess delay of disability progression by MS treatments

MRI T2 lesion burden in multiple sclerosis: a plateauing relationship with clinical disability

The efficacy of teriflunomide in patients who received prior disease-modifying treatments: Subgroup analyses of the teriflunomide phase 3 TEMSO and TOWER studies

Pooled safety and tolerability data from four placebo-controlled teriflunomide studies and extensions

Glatiramer acetate reduces the proportion of new MS lesions evolving into "black holes"

Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients with Relapsing and Primary Progressive Multiple Sclerosis

Diffusion tensor fractional anisotropy of the normal-appearing seven segments of the corpus callosum in healthy adults and relapsing-remitting multiple sclerosis patients

Long-term safety and efficacy of teriflunomide in patients with relapsing multiple sclerosis: Results from the TOWER extension study

Polygenic liability for anxiety in association with comorbid anxiety in multiple sclerosis

Teriflunomide reduces relapse-related neurological sequelae, hospitalizations and steroid use

Association of Vitamin D Polygenic Risk Scores and Disease Outcome in People With Multiple Sclerosis

Suchergebnisse filtern